Menu Search
Equities

Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT

JMAS:JKT

Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PT

Actions
FinancialsLife Insurance
  • Price (IDR)53.00
  • Today's Change0.00 / 0.00%
  • Shares traded2.14m
  • 1 Year change+3.92%
  • Beta0.8995
Data delayed at least 10 minutes, as of May 02 2024 10:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk is an Indonesia-based sharia life insurance company. The Company provides group products and individual products. Its group products include financing partner, JMA Fixed Financing, JMA UMK Financing, JMA Mulia, JMA Amalia, JMA Sejahtera Insurance, JMA Karimah Insurance, JMA Asyifa Care Insurance, JMA Zawjayn Partner' Financing Insurance and JMA Zawjayn Fixed Financing Insurance. The individual products include JMA Salama Microinsurance, JMA Ilma Insurance, JMA Mumtaza Insurance, JMA Asyifa Insurance, JMA Aghnia Insurance, additional total permanent disability insurance and JMA Ammar Insurance. Its JMA Mulia is a group term life insurance product that provides insurance benefits if the participant passes away due to an accident or not due to an accident during the contract period. Its JMA Asyifa Insurance provides reimbursement for inpatient treatment costs at a hospital if the participant experiences illness during the insurance period.

  • Revenue in IDR (TTM)142.08bn
  • Net income in IDR2.53bn
  • Incorporated2014
  • Employees44.00
  • Location
    Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk PTGraha Kospin Jasa Lt. 5 JlJend Gatot Soebroto Kav. 1JAKARTA SELATAN 12870IndonesiaIDN
  • Phone+62 2 182470083
  • Websitehttps://www.jmasyariah.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.